Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 4, 2007, Pages 380-381

  Yamada, Yumi ^a   Yoshihara, Shigemi ^a   Arisaka, Osamu ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; GLUCOCORTICOID; IMATINIB; MEPOLIZUMAB; STEROID; SUPLATAST TOSYLATE;

CASE REPORT; CHILD; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; EOSINOPHIL COUNT; EOSINOPHIL CYSTITIS; EOSINOPHILIC GASTRITIS; GROWTH RETARDATION; HUMAN; HYPEREOSINOPHILIC SYNDROME; LETTER; MALE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TREATMENT RESPONSE;

EID: 35348938090     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60558-3     Document Type: Letter

References (4)

1. Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54:1-27.
2. Katz HT, Haque SJ, Hsieh FH. Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr. 2005;146:134-136.
3. Wilkins HJ, Crane MM, Williams WV, et al. Hypereosinophilic syndrome: an update. Am J Hematol. 2005;80:148-157.
4. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry. 1998;34:207-215.